Bad News for Charcuterie Fans; Pancreatic Cancer Screening; Cancer Panel Appointees

Bad News for Charcuterie Fans; Pancreatic Cancer Screening; Cancer Panel Appointees

July 14, 2022 0 By Jennifer Walker

The French ham and cured sausage industry took a hit this week when France’s Agency for Food, Environmental and Occupational Health and Safety confirmed the connection between the nitrates found in processed meats and colorectal cancer. (The Guardian)

Regular screening for patients at high risk of developing pancreatic cancer detects cancer at an earlier stage, resulting in better survival rates. (Johns Hopkins Medicine, Journal of Clinical Oncology)

President Biden appointed Elizabeth M. Jaffee, MD, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, to serve as chair of the President’s Cancer Panel. Biden also appointed Mitchel Berger, MD, of the Brain Tumor Research Center at the University of California San Francisco, and Carol Brown, MD, of Memorial Sloan Kettering Cancer Center, to the panel.

BeiGene announced the FDA is delaying action on the biologics license application for tislelizumab as second-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma. The agency has been unable to conduct required inspections in China due to COVID-19 related travel restrictions.

Compared with privately insured patients, people with Medicaid or no insurance were significantly more likely to be diagnosed with late-stage (III/IV) cancer for stageable cancers. (CA: A Cancer Journal for Clinicians).

Whole exome sequencing can help predict which cancer patients are likely to respond to immunotherapy. (NYU, Nature Communications)

The National Comprehensive Cancer Network has published new clinical practice guidelines for treatment of pediatric central nervous system cancers.

Rebecca M. Blank, president-elect of Northwestern University, said she will be unable to take over as president of the Chicago-area school after being diagnosed with an aggressive form of cancer. (Northwestern Now)

An investigational cancer therapy called AZD1390 promoted regeneration of damaged nerves and restored sensory and motor function after spinal injury in lab studies and animal models. (University of Birmingham, Clinical and Translational Medicine)

There’s a case to be made for including dentists in cancer care teams. (NYU)

  • author['full_name']

    Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.